aColumbia University, New York, New York
bNovartis Pharmaceuticals, East Hanover, New Jersey, USA
cMedAvante Inc., Hamilton, Ontario, Canada
dMerck Research Laboratories, Whitehouse Station, New Jersey
eQuintiles and the University of California, San Diego, California, USA
fOntario Cancer Biomarker Network, Toronto, Ontario, Canada
gPsychiatric Research Institute and Frederiksborg General Hospital, Copenhagen, Denmark
Correspondence to Janet B.W. Williams, DSW, MedAvante Inc., 100 American Metro Blvd., Suite 106, Hamilton, NJ 08619, USA
Tel: +609 528 9472; fax: +609 528 9405;
e-mail: [email protected] or [email protected]
Received 29 April 2007 Accepted 21 January 2008
